Advanced glycation end products/peptides: an in vivo investigation.
about
Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies.
P2860
Advanced glycation end products/peptides: an in vivo investigation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Advanced glycation end products/peptides: an in vivo investigation.
@ast
Advanced glycation end products/peptides: an in vivo investigation.
@en
type
label
Advanced glycation end products/peptides: an in vivo investigation.
@ast
Advanced glycation end products/peptides: an in vivo investigation.
@en
prefLabel
Advanced glycation end products/peptides: an in vivo investigation.
@ast
Advanced glycation end products/peptides: an in vivo investigation.
@en
P2093
P2860
P356
P1476
Advanced glycation end products/peptides: an in vivo investigation.
@en
P2093
Bonfante L
Seraglia R
P2860
P304
P356
10.1196/ANNALS.1333.032
P407
P577
2005-06-01T00:00:00Z